To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Find out MoreBiopharma Cred. Share Price | |
---|---|
Price | 0.876 |
Bid | 0.874 |
Ask | 0.878 |
Change | -0.002 (-0.23%) |
Volume | 1,232,752 |
Open | 0.878 |
High | 0.878 |
Low | 0.874 |
Prev. Close | 0.878 |
Currency | USD |
---|---|
Issue Country | GB |
Shares in Issue | 1.23b |
Market Capitalisation | $1.08b |
Market Size | 5,000 |
52 Week High | 0.966 |
52 Week High Date | 17-May-2023 |
52 Week Low | 0.81 |
52 Week Low Date | 09-Nov-2023 |
# Trades | 43 |
---|---|
Vol. Sold | 84,405 |
Sold Value | $73.84k |
Vol. Bought | 373,943 |
Bought Value | $328.27k |
PE Ratio | 10.57971 |
Earnings | 0.0828 |
Dividend | 0.0525 |
Yield | 5.993% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
25-Apr-24 | 17:17:33 | 0.87599 | 513 | Unknown* | 0.874 | 0.878 | 449.38 | O Ordinary Was reported as OTC |
25-Apr-24 | 16:59:30 | 0.8759 | 474 | Unknown* | 0.874 | 0.878 | 415.18 | O Ordinary Was reported as OTC |
25-Apr-24 | 16:58:12 | 0.87604 | 1,079 | Unknown* | 0.874 | 0.878 | 945.25 | O Ordinary Was reported as OTC |
25-Apr-24 | 16:35:04 | 0.876 | 2,564 | Buy* | 0.874 | 0.878 | 2,246 | UT Uncrossing Trade |
25-Apr-24 | 16:29:34 | 0.874 | 2,399 | Sell* | 0.874 | 0.878 | 2,097 | A Automatic Execution |
25-Apr-24 | 16:15:36 | 0.87452 | 5,175 | Sell* | 0.874 | 0.878 | 4,526 | O Ordinary |
25-Apr-24 | 16:15:36 | 0.87452 | -5,175 | Unknown* | 0.874 | 0.878 | -4,526 | O Ordinary Deletion |
25-Apr-24 | 16:15:36 | 0.87452 | 5,175 | Sell* | 0.874 | 0.878 | 4,526 | O Ordinary |
25-Apr-24 | 14:15:37 | 0.87737 | 17,500 | Buy* | 0.874 | 0.878 | 15.35k | O Ordinary |
25-Apr-24 | 13:00:55 | 0.878 | 2 | Buy* | 0.874 | 0.878 | 1.76 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
27-Mar-24 | 27-Mar-24 | Buy | Sapna Shah held the position of Non-Executive Director at the time of this trade.Sapna Shah | 71.51 | GBX | 20,000 | 75,275 |
25-Mar-24 | 15-Mar-24 | Buy Dividends | Harry Abraham Hyman held the position of Chairman at the time of this trade.Harry Abraham Hyman | 69.21 | GBX | 109 | 208,900 |
22-Jan-24 | 05-Jan-24 | Buy Dividends | Harry Abraham Hyman held the position of Chairman at the time of this trade.Harry Abraham Hyman | 72.47 | GBX | 126 | 208,791 |
16-May-23 | 05-May-23 | Buy Dividends | Harry Abraham Hyman held the position of Chairman at the time of this trade.Harry Abraham Hyman | 73.51 | GBX | 103 | 208,665 |
29-Mar-23 | 27-Mar-23 | Buy | Sapna Shah held the position of Non-Executive Director at the time of this trade.Sapna Shah | 97.00 | GBX | 15,075 | 55,275 |